BHVN

Biohaven Pharmaceutical Holding Company Ltd.

Delisted

BHVN was delisted on the 3rd of October, 2022.

238 hedge funds and large institutions have $4.78B invested in Biohaven Pharmaceutical Holding Company Ltd. in 2020 Q4 according to their latest regulatory filings, with 50 funds opening new positions, 79 increasing their positions, 89 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
238
Holders Change
+23
Holders Change %
+10.7%
% of All Funds
4.22%
Holding in Top 10
12
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-7.69%
% of All Funds
0.21%
New
50
Increased
79
Reduced
89
Closed
26
Calls
$282M
Puts
$176M
Net Calls
+$106M
Net Calls Change
+$56.9M
Name Holding Trade Value Shares
Change
Shares
Change %
Squarepoint
251
Squarepoint
New York
-$895K -13,774 Closed
SSA
252
Schonfeld Strategic Advisors
New York
-$879K -13,525 Closed
Jennison Associates
253
Jennison Associates
New York
-$618K -9,503 Closed
CIS
254
Capital International Sarl
California
-$604K -9,286 Closed
NAM
255
Nexpoint Asset Management
Texas
-$390K -6,000 Closed
BAM
256
Blueshift Asset Management
New Jersey
-$276K -4,253 Closed
QI
257
QS Investors
New York
-$235K -3,600 Closed
AC
258
Allstate Corporation
Illinois
-$223K -3,430 Closed
PFS
259
Prospera Financial Services
Texas
-$126K -1,943 Closed
SIA
260
SeaBridge Investment Advisors
New Jersey
-$20K -300 Closed
AF
261
Advisornet Financial
Minnesota
-$10K -150 Closed
CWC
262
Carolinas Wealth Consulting
North Carolina
-$1K -18 Closed